Israel’s Aspect Imaging develops small, affordable and innovative MRI scanners; Scientists at Israel’s Technion Institute have stimulated the feel-good center in mice and discovered that their immune cells were able to kill twice as much bacteria than those of non-stimulated mice, and much more.
By: Michael Ordman
ISRAEL’S MEDICAL ACHIEVEMENTS
The power to see inside
Israel’s Aspect Imaging develops small, affordable and innovative MRI scanners. Its non-claustrophobic WristView scans limbs (e.g. wrist and hand) and Embrace scans newborns. WristView has just received the European CE Mark, to add to its existing US FDA approval.
http://www.globes.co.il/en/article-israeli-mri-co-aspect-imaging-raises-20m-1001139665
Good feelings can kill bacteria
Scientists at Israel’s Technion Institute have stimulated the feel-good center in mice and discovered that their immune cells were able to kill twice as much bacteria than those of non-stimulated mice. The results, published in nature medicine, could explain the placebo effect.
http://www.timesofisrael.com/israeli-study-shows-placebos-physically-boost-immunity/
http://www.nature.com/nm/journal/vaop/ncurrent/nm.4133/metrics/news
New treatment for cancer
Israel’s Rosetta Genomics has received a US patent for its miR-34 treatments of p53-negative cancers including lymphoma, breast cancer, ovarian cancer, liver cancer, skin cancer, certain types of lung cancer, and others.
http://rosettagx.com/files/press-releases/1468255718927d275d893bf3f293d526ca3435b8da.pdf
A better test for prostate cancer
Israeli founded Cleveland Diagnostics (CDX) is developing a technology and test kit that can eradicate inconclusive prostate-specific antigen (PSA) tests. CDX says it will save the $4000 cost per negative biopsy, currently necessary in 70% of current testing.
http://www.timesofisrael.com/new-prostate-cancer-test-strives-to-slash-biopsies/
And another one
Israel’s Micromedic Technologies (part of Israel’s Bio-Light Life Sciences) reported positive results in a trial of its prostate cancer diagnosis solution. Its CellDetect technology was used to diagnose samples from 18 patients and healthy subjects, and both groups were accurately diagnosed.
http://www.globes.co.il/en/article-micromedic-jumps-80-after-cancer-diagnosis-trial-success-1001138112
Another step forward in fighting melanoma
Almost a year ago, Tel Aviv University researchers found what triggers melanoma cells to become malignant tumors in the brain. Now they have uncovered an early warning of that event by detecting the brain’s inflammatory response to microscopic invading tumor cells.
http://www.timesofisrael.com/researchers-find-way-to-spot-tumor-cells-invading-the-brain/
Upgraded spine surgery robots
Israel’s Mazor Robotics has launched FDA-approved Mazor X, “a transformative platform for spine surgeries”. Mazor’s current range guides surgeons in spine operations. The new platform also helps planning through to verification. Israel’s Medtronic has already bought 15.
http://www.mazorrobotics.com/mazor-robotics-unveils-mazor-x-a-transformative-platform-for-spine-surgeries/
Snack vegetables to replace fast foods
Israel’s Origene Seeds is developing a range of snack vegetables which aim to replace fast food snacks. The “Sweet Drops” mini-size cucumbers and peppers have a long shelf-life and will be marketed in special packets as “Finger Food” for work, school or leisure.
http://www.israelagri.com/?CategoryID=404&ArticleID=1272
Click here for all of this week’s Good News from Israel.